PMC:7102591 / 10523-10772 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"337","span":{"begin":37,"end":39},"obj":"Gene"},{"id":"344","span":{"begin":6,"end":8},"obj":"Disease"},{"id":"345","span":{"begin":72,"end":84},"obj":"Disease"},{"id":"346","span":{"begin":92,"end":94},"obj":"Disease"},{"id":"347","span":{"begin":218,"end":228},"obj":"Disease"}],"attributes":[{"id":"A337","pred":"tao:has_database_id","subj":"337","obj":"Gene:1431"},{"id":"A344","pred":"tao:has_database_id","subj":"344","obj":"MESH:D001172"},{"id":"A345","pred":"tao:has_database_id","subj":"345","obj":"MESH:D007249"},{"id":"A346","pred":"tao:has_database_id","subj":"346","obj":"MESH:D001172"},{"id":"A347","pred":"tao:has_database_id","subj":"347","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"s for RA treatment [36]. Even though CS efficacy in rapidly suppressing inflammation during RA initial course or flares is well recognized [37], their downside is the broad spectrum of adverse events, including severe infections and the high risk of"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T50","span":{"begin":37,"end":39},"obj":"Body_part"}],"attributes":[{"id":"A50","pred":"fma_id","subj":"T50","obj":"http://purl.org/sig/ont/fma/fma284995"}],"text":"s for RA treatment [36]. Even though CS efficacy in rapidly suppressing inflammation during RA initial course or flares is well recognized [37], their downside is the broad spectrum of adverse events, including severe infections and the high risk of"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T141","span":{"begin":6,"end":8},"obj":"Disease"},{"id":"T143","span":{"begin":72,"end":84},"obj":"Disease"},{"id":"T144","span":{"begin":92,"end":94},"obj":"Disease"},{"id":"T146","span":{"begin":218,"end":228},"obj":"Disease"}],"attributes":[{"id":"A141","pred":"mondo_id","subj":"T141","obj":"http://purl.obolibrary.org/obo/MONDO_0005272"},{"id":"A142","pred":"mondo_id","subj":"T141","obj":"http://purl.obolibrary.org/obo/MONDO_0008383"},{"id":"A143","pred":"mondo_id","subj":"T143","obj":"http://purl.obolibrary.org/obo/MONDO_0021166"},{"id":"A144","pred":"mondo_id","subj":"T144","obj":"http://purl.obolibrary.org/obo/MONDO_0005272"},{"id":"A145","pred":"mondo_id","subj":"T144","obj":"http://purl.obolibrary.org/obo/MONDO_0008383"},{"id":"A146","pred":"mondo_id","subj":"T146","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"s for RA treatment [36]. Even though CS efficacy in rapidly suppressing inflammation during RA initial course or flares is well recognized [37], their downside is the broad spectrum of adverse events, including severe infections and the high risk of"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T83","span":{"begin":20,"end":22},"obj":"http://purl.obolibrary.org/obo/CLO_0001313"}],"text":"s for RA treatment [36]. Even though CS efficacy in rapidly suppressing inflammation during RA initial course or flares is well recognized [37], their downside is the broad spectrum of adverse events, including severe infections and the high risk of"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T74","span":{"begin":6,"end":8},"obj":"Chemical"},{"id":"T75","span":{"begin":37,"end":39},"obj":"Chemical"},{"id":"T77","span":{"begin":92,"end":94},"obj":"Chemical"}],"attributes":[{"id":"A74","pred":"chebi_id","subj":"T74","obj":"http://purl.obolibrary.org/obo/CHEBI_73810"},{"id":"A75","pred":"chebi_id","subj":"T75","obj":"http://purl.obolibrary.org/obo/CHEBI_73462"},{"id":"A76","pred":"chebi_id","subj":"T75","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"},{"id":"A77","pred":"chebi_id","subj":"T77","obj":"http://purl.obolibrary.org/obo/CHEBI_73810"}],"text":"s for RA treatment [36]. Even though CS efficacy in rapidly suppressing inflammation during RA initial course or flares is well recognized [37], their downside is the broad spectrum of adverse events, including severe infections and the high risk of"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T15","span":{"begin":72,"end":84},"obj":"http://purl.obolibrary.org/obo/GO_0006954"}],"text":"s for RA treatment [36]. Even though CS efficacy in rapidly suppressing inflammation during RA initial course or flares is well recognized [37], their downside is the broad spectrum of adverse events, including severe infections and the high risk of"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T51","span":{"begin":6,"end":8},"obj":"Phenotype"},{"id":"T52","span":{"begin":92,"end":94},"obj":"Phenotype"},{"id":"T53","span":{"begin":211,"end":228},"obj":"Phenotype"}],"attributes":[{"id":"A51","pred":"hp_id","subj":"T51","obj":"http://purl.obolibrary.org/obo/HP_0001370"},{"id":"A52","pred":"hp_id","subj":"T52","obj":"http://purl.obolibrary.org/obo/HP_0001370"},{"id":"A53","pred":"hp_id","subj":"T53","obj":"http://purl.obolibrary.org/obo/HP_0032169"}],"text":"s for RA treatment [36]. Even though CS efficacy in rapidly suppressing inflammation during RA initial course or flares is well recognized [37], their downside is the broad spectrum of adverse events, including severe infections and the high risk of"}

{"project":"2_test","denotations":[{"id":"32205186-31396235-4826883","span":{"begin":140,"end":142},"obj":"31396235"}],"text":"s for RA treatment [36]. Even though CS efficacy in rapidly suppressing inflammation during RA initial course or flares is well recognized [37], their downside is the broad spectrum of adverse events, including severe infections and the high risk of"}